lung cancer
Conditions
Interventions
Index test:Novel tracer 99mTc-FAPI SPECT/CT fusion imaging
Target/background ratio
Sponsors
The First Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Age >18, male or female; (2) Patients with lung occupying lesions diagnosed by CT and clinically suspected or confirmed lung cancer; (3) Able to obtain puncture biopsy or postoperative pathological results; (4) Participants who were able to provide informed consent (signed by the participant, parent, or legal representative) with good compliance.
Exclusion criteria
Exclusion criteria: (1) Serious abnormalities in liver and kidney function; (2) Women who are preparing for pregnancy, pregnant and breastfeeding; (3) Those who suffer from claustrophobia or are unable to lie still and flat for more than 15 minutes for various reasons; (4) No pathological results or other diagnostic basis; (5) Concomitant other tumors or other conditions deemed by the investigator to be unsuitable for participation in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax;Target/background ratio;Positive rate, negative rate;Accuracy, sensitivity, specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tracer concentration of metastatic lesions; | — |
Countries
China
Contacts
Public ContactHuiqi Gao
Department of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University
Outcome results
None listed